Biohacking
Brain Aging in Midlife: Evidence Beyond the Headlines
Dec 10, 2025
How to read claims about a critical brain-aging window, distinguish population patterns from personal forecasts, and focus on supported actions.
Brain aging isn't inevitable decline—it's metabolic stress you can address. Explore strategies for preserving cognitive function, from neuronal insulin resistance to network stability interventions. Evidence-based approaches for the critical window between 40-60.
Biohacking Articles
Livestreams on Cognitive Decline
Live Q&A sessions from Neurofeedback & Chill where Dr. Hill demonstrates protocols, answers viewer questions, and explores cognitive decline applications in real-time with QEEG examples and brain training discussions.
Latest Sessions
Livestream
The Alzheimer's Sleep Paradox: When More Sleep Isn't Better
A new Alzheimer's study reports that early amyloid pathology can keep the brain from settling into normal NREM sleep, but the experiment was in mice. At the same time, new human studies link unusually long sleep with tau biomarkers, Alzheimer's-like brain atrophy, and poorer cognition. In this video, we separate cause from warning signal, explain the role of microglia and glymphatic clearance, and show why the right question is not simply, "How many hours did you sleep?" 🧠 KEY TAKEAWAYS: • The new microglia result comes from a mouse mechanism study • Early amyloid pathology reduced NREM sleep through reactive microglia even before plaque burden became severe • Long self-reported sleep tracks with Alzheimer's-related biomarkers in some human cohorts, but it may be a marker of early disease or fragmented sleep • Normal human NREM physiology appears to support overnight movement of amyloid beta and tau from brain to plasma • Sleep duration, sleep architecture, sleep quality, and time in bed are different measurements • Do not deliberately restrict needed sleep; investigate a persistent change in sleep need or daytime function KEY RESEARCH CITED: • Constantino et al. (2026). Reactive microglia drove plaque-associated NREM sleep loss in APP/PS1 mice. Alzheimer's & Dementia. DOI: 10.1002/alz.71579 • Young et al. (2026). Long self-reported sleep showed a nonlinear association with plasma p-tau181 in 2,410 Framingham participants. Alzheimer's & Dementia. DOI: 10.1002/alz.71499 • Anagnostakis et al. (2026). Sleep duration showed U-shaped associations with an Alzheimer's-like MRI signature and cognition in 38,816 UK Biobank participants. Alzheimer's & Dementia. DOI: 10.1002/alz.71528 • Dagum et al. (2026). A randomized crossover study supported sleep-active movement of amyloid beta and tau from brain to plasma in humans. Nature Communications. DOI: 10.1038/s41467-026-68374-8 #Alzheimers #Sleep #BrainHealth #Dementia #GlymphaticSystem #Microglia #Neuroscience #HealthyAging #DrAndrewHill #NeurofeedbackAndChill **Resources / Work with Dr. Hill:** 📞 Free consultation: https://calendly.com/drhill1 🧠 Peak Brain Institute: https://peakbraininstitute.com 📖 Dr. Hill's articles and books: https://www.andrewhillphd.com/
Livestream
Your Brain on Hormones: Alzheimer's, Your Cycle, PMDD, & Menopause
If your brain feels like it changes through the month, sharper some weeks, foggier in the days before your period, you're not imagining it. And if you've hit your 40s and the fog stopped lifting, that's not in your head either. Estrogen and progesterone aren't just reproductive hormones. They're master neuromodulators of the cortex, and when they move, the brain moves with them, measurably, on the EEG. In this video we trace hormones and the brain across the whole female lifespan: how your cycle shifts your alpha rhythm, how PMDD pulls frontal alpha asymmetry into a depression-type pattern, and what happens to the brain at menopause. The through-line: these shifts are individual, which is exactly why you measure instead of assume. 🧠 KEY TAKEAWAYS: • Estrogen activates and builds (serotonin, dopamine, acetylcholine, plasticity, glucose metabolism, blood flow, BDNF); progesterone, via its metabolite allopregnanolone, a GABA-A neurosteroid, calms and inhibits. Two hormones, opposite jobs, both tuning the cortex. • Your resting EEG shifts across the menstrual cycle: peak alpha frequency runs highest in the luteal phase and lowest in the late follicular phase; alpha power tends to drop and theta to rise approaching ovulation. • These cycle effects are real but heterogeneous. They show up clearly in some women and barely in others. That individual variability is the whole point: you measure, you don't assume. • PMDD isn't "bad PMS." Women with PMDD show a depression-type frontal alpha asymmetry that emerges specifically in the luteal phase, and frontal alpha asymmetry is a trainable neurofeedback target. • The leading model of PMDD is abnormal CNS sensitivity to a normal hormonal shift (allopregnanolone/GABA-A), not abnormal hormone levels. • Menopause withdraws estrogen's multi-system support at once. Mosconi's imaging shows the transition is a critical window for long-term brain health. HRT timing, exercise, sleep, diet, and neurofeedback each help. 📚 Topics • Estrogen and progesterone: the brain's master neuromodulators • The monthly tide, your cycle on the EEG (alpha, IAF, theta) • When the tide pulls too hard, PMDD and frontal alpha asymmetry • The big shift, perimenopause, menopause, and what helps • Closing + Peak Brain CTA (Brain Awareness Month finale) Research Cited: • Brötzner et al. (2014). Peak alpha frequency highest in luteal, lowest in late follicular phase. Brain Research. DOI: 10.1016/j.brainres.2014.06.034 • García-Granados et al. (2026). Systematic review: alpha decreases, theta increases in late follicular phase, but literature is heterogeneous. Arch Womens Ment Health. DOI: 10.1007/s00737-025-01654-2 • Accortt & Allen (2006). PMDD shows depression-type frontal alpha asymmetry emerging in the luteal phase. J Abnorm Psychol. DOI: 10.1037/0021-843X.115.1.179 • Schmidt et al. (2017). PMDD symptoms are triggered by the normal cyclical change in ovarian steroids, not by abnormal hormone levels (CNS-sensitivity model). Am J Psychiatry. DOI: 10.1176/appi.ajp.2017.16101113 • Bäckström et al. (2021). Randomized trial of the neurosteroid sepranolone for PMDD; targets the allopregnanolone/GABA-A mechanism. Psychoneuroendocrinology. DOI: 10.1016/j.psyneuen.2021.105426 • Mosconi et al. (2017a). Sex differences in Alzheimer risk. Neurology. DOI: 10.1212/WNL.0000000000004425 • Mosconi et al. (2017b). Perimenopause and emergence of an Alzheimer's bioenergetic phenotype. PLoS One. DOI: 10.1371/journal.pone.0185926 • Maki & Henderson (2012). HRT critical-window hypothesis for cognition. Climacteric. DOI: 10.3109/13697137.2012.660613 RESOURCES: 📞 Book a free consultation: https://calendly.com/drhill1 🧠 Peak Brain Institute: https://peakbraininstitute.com 🧠 QEEG brain mapping: https://peakbraininstitute.com/brain-mapping 🌐 Remote Neurofeedback: https://peakbraininstitute.com/remote-neurofeedback-programs 📖 Dr. Hill's books: https://www.peakbrainpress.com and QUIZ: https://www.giftedandtortured.com/ #Hormones #MenstrualCycle #PMDD #Menopause #Perimenopause #BrainFog #Estrogen #QEEG #Neurofeedback #DrAndrewHill #NeurofeedbackAndChill #Alzheimers
Livestream
There's Finally a Blood Test for Alzheimer's. Should You Get It?
For decades, getting a real answer about Alzheimer's meant a spinal tap, a PET scan, or waiting until the symptoms were obvious. As of 2025 there's a fourth option: a single blood draw. The FDA cleared the first one in May, and by August you could order it from a national lab. In this video we break down what the test actually measures, who it's really for (and who it's not), the caveats nobody mentions, and the one question it can't touch - how your brain is actually functioning right now. 🧠 KEY TAKEAWAYS: • The FDA cleared the first blood test for Alzheimer's: the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio (Fujirebio) on May 16, 2025. It's a diagnostic aid, not a screening test. • It's intended for adults 55+ who already have signs or symptoms of cognitive decline, evaluated in a clinical setting, NOT for healthy, asymptomatic people who feel fine and want to peek around the corner. • p-tau217 is the standout blood biomarker. The test's ratio agrees with amyloid PET about 92% of the time for positives and about 97% for negatives. • A positive result means amyloid is present - it does NOT by itself mean you have Alzheimer's. Amyloid shows up in cognitively normal people too, and kidney function can shift the number. • The blood test measures pathology: is excess amyloid there? A QEEG brain map measures function - how is your brain actually working? Those are different questions, and function is the trainable one. KEY RESEARCH CITED: • U.S. FDA (May 16, 2025). First blood test cleared to aid Alzheimer's diagnosis: Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio (Fujirebio Diagnostics). In vitro diagnostic, 510(k), Breakthrough Device. Validation: multicenter study of 499 plasma samples from cognitively impaired adults vs amyloid PET/CSF with 91.7% positive percent agreement, 97.3% negative percent agreement, under 20% indeterminate. • Palmqvist et al., Nature Medicine (2025)" SEPARATE multicenter study of 1,767 participants with cognitive symptoms on a fully automated plasma p-tau217 platform; ~85% accuracy in primary care. DOI 10.1038/s41591-025-03622-w (PMID 40205199). • Ashton et al., JAMA Neurology (2024): plasma p-tau217 immunoassay establishes p-tau217 as the standout blood biomarker for Alzheimer's pathology. DOI 10.1001/jamaneurol.2023.5319. • Labcorp (Aug 18, 2025): nationwide launch of the FDA-cleared plasma p-tau217/β-amyloid 1-42 ratio test. • U.S. FDA (Aug 2025): subcutaneous lecanemab autoinjector (Leqembi IQLIK) approved for at-home maintenance dosing; lecanemab (Leqembi) and donanemab (Kisunla) approved for MCI/mild AD. RESOURCES: 📞 Book a free consultation: https://calendly.com/drhill1 🧠 Peak Brain Institute: https://peakbraininstitute.com 🗺️ QEEG Brain Mapping: https://peakbraininstitute.com/brain-mapping 📖 Dr. Hill's books: https://www.peakbrainpress.com #Alzheimers #BloodTest #pTau217 #BrainHealth #QEEG #DrAndrewHill #NeurofeedbackAndChill #Neuroscience #Neurofeedback #Dementia #BrainMapping #Amyloid #BrainAwarenessMonth
Livestream
🧠 A Critical Aging Window: The One Thing That Ages You After 44
🧠 NEW RESEARCH REVEALS: Your Brain Has a Critical "Tipping Point" at Age 44 Scientists at Stony Brook University have discovered that brain aging follows a precise S-curve with specific transition points—and the first critical change happens decades earlier than previously thought. In this video, we explore groundbreaking research published in PNAS on March 10, 2025, showing how your brain's metabolic health begins declining at age 44, long before any cognitive symptoms appear. Learn why this happens, how neuronal insulin resistance creates an "energy crisis" in your brain, and why ketones might be the alternative fuel your aging brain desperately needs. Most importantly, discover why the ages 40-59 represent a critical intervention window where metabolic support yields maximum benefits—and why waiting until symptoms appear might be too late. This isn't just academic research—it's a roadmap for potentially transforming how we approach brain health and cognitive aging. Understanding this hidden timeline could significantly impact your cognitive future. 👉 KEY POINTS: - Brain aging follows a nonlinear S-shaped curve with transition points at ages 44, 67, and 90 - Neuronal insulin resistance prevents your brain from using glucose effectively - Ketones provide an alternative fuel source that bypasses insulin resistance - The midlife period (40-59) offers the maximum benefit from metabolic interventions This research collaboration includes scientists from Massachusetts General Hospital, Mayo Clinic, Oxford University, and Memorial Sloan Kettering. #BrainHealth #CognitiveDecline #NeuralAging #BrainResearch #Ketones #MetabolicHealth 💬 Drop your questions in the chat—let’s explore the brain together! 👉 Watch LIVE: Monday 6pm PT or check out the streams later! 📺 YouTube.com/DrHill #NeurofeedbackAndChill #WordFinding #BrainHacking #Neurofeedback #CognitiveEnhancement #Biohacking #Neurofeedback #AMA 👉 Read more: https://andrewhillphd.com/critical-aging-window-the-one-thing-that-ages-you-after-44/ https://news.stonybrook.edu/newsroom/press-release/medical/scientists-identify-critical-midlife-window-for-preventing-age-related-brain-decline/ https://www.pnas.org/doi/10.1073/pnas.2416433122 👉 Ready to optimize your brain? ttps://peakbraininstitute.com/brain-training/neurofeedback/ 👉 Book a consult: https://calendly.com/drhill1 👉 Book a discount QEEG: https://peakbraininstitute.com/special/
